Covered recipient · General Payments record
KEREN B HORN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$16,340.69
- Reported across 307 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $444.14 | 23 |
| Education | $68.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $185.29 | 11 |
| Janssen Biotech, Inc. | $68.99 | 1 |
| GENZYME CORPORATION | $65.62 | 2 |
| Amgen Inc. | $43.76 | 2 |
| PFIZER INC. | $40.62 | 2 |
| Arcutis Biotherapeutics, Inc. | $37.31 | 2 |
| Fresenius Kabi USA, LLC | $18.57 | 1 |
| Galderma Laboratories, L.P. | $18.14 | 1 |
| REVANCE THERAPEUTICS, INC. | $18.04 | 1 |
| Biofrontera Inc. | $16.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.04 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938907 | CMS |
| ABBVIE INC. | $15.53 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938909 | CMS |
| ABBVIE INC. | $0.09 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938911 | CMS |
| ABBVIE INC. | $16.35 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938913 | CMS |
| ABBVIE INC. | $22.83 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938915 | CMS |
| ABBVIE INC. | $18.19 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938917 | CMS |
| ABBVIE INC. | $18.84 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938919 | CMS |
| ABBVIE INC. | $16.75 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938921 | CMS |
| ABBVIE INC. | $25.99 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938923 | CMS |
| ABBVIE INC. | $22.74 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938925 | CMS |
| ABBVIE INC. | $5.94 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103938927 | CMS |
| Amgen Inc. | $21.29 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117280718 | CMS |
| Amgen Inc. | $22.47 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117280720 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.86 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121057851 | CMS |
| Arcutis Biotherapeutics, Inc. | $19.45 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121057853 | CMS |
| Biofrontera Inc. | $16.79 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089609876 | CMS |
| Fresenius Kabi USA, LLC | $18.57 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146949134 | CMS |
| Galderma Laboratories, L.P. | $18.14 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145304761 | CMS |
| GENZYME CORPORATION | $33.09 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719326 | CMS |
| GENZYME CORPORATION | $32.53 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139719368 | CMS |
| Janssen Biotech, Inc. | $68.99 | 03/20/2024 | Education | Undisputed | 01/23/2026 | 1078580672 | CMS |
| PFIZER INC. | $16.60 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131167538 | CMS |
| PFIZER INC. | $24.02 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131880283 | CMS |
| REVANCE THERAPEUTICS, INC. | $18.04 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147920334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.